Using Accelerator Mass Spectrometry in Clinical Pharmacology

<p>This episode is an interview with Dr. Wouter Vaes, the Chief Science Officer of Peregrion. We discuss how accelerator mass spectrometry is being used in early clinical development for drug metabolism and pharmacokinetics. We discuss using this technology to support development of oncology agents, determining absolute bioavailability without IV toxicology work, and more. </p><p><br></p><p>Links discussed in the show:</p><ul><li>You can contact Wouter by email: wouter.vaes@peregrion.com </li><li><a href="https://www.linkedin.com/company/peregrion/posts/?feedView=all" target="_blank" rel="noopener noreferer">Connect with Peregrion on LinkedIn</a> or their <a href="https://www.peregrion.com/" target="_blank" rel="noopener noreferer">website</a></li><li><a href="https://www.peregrion.com/symposium-microtracer-ams-for-next-gen-drug-development/" target="_blank" rel="noopener noreferer">Symposium on microtracer studies </a></li><li><a href="https://www.fda.gov/media/72279/download" target="_blank" rel="noopener noreferer">FDA guidance on safety testing of drug metabolites</a></li><li><a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2691" target="_blank" rel="noopener noreferer">White paper on human ADME data</a> </li><li>You can c<a href="https://go.teuschersolutions.com/linkedin" target="_blank" rel="noopener noreferer">onnect with Nathan on LinkedIn</a> and send me a message </li><li><a href="https://go.teuschersolutions.com/contact" target="_blank" rel="noopener noreferer">Send Nathan a message</a> </li><li><a href="https://go.teuschersolutions.com/newsletter" target="_blank" rel="noopener noreferer">Sign up for Nathan’s newsletter</a> </li></ul><p><br></p><p>Copyright Teuscher Solutions LLC</p><p>All Rights Reserved</p>